ARCHIVES

Surveillance Treatment Option For Low-Risk Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 7 | July 30, 2010

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

In Brief: Jack White Resigns As Director Of Howard Cancer Center; Roberson to Retire From Centers Program

June 1, 1984